17.01.18
CTD Holdings’ European Clinical Trial Adopted by National Institute for Health Research of England...
Read more04.01.18
Adina Wise is undertaking a research study to determine the rates of Parkinson disease in patients and family members with Niemann-Pick Disease (NPC and ASMD)...
Read more03.01.18
NPUK Chair, Will Evans, gives his 2018 message...
Read more13.12.17
CTD Holdings, Inc. today announced that it has received rare pediatric disease designation from the FDA for its Trappsol® Cyclo™ drug...
Read more20.11.17
A letter to the NPC community from Orphazyme’s CEO, Anders Hinsby. We are please to also provide translations (from English into German, French, Spanish, Italian, Polish) of this letter.
Read more
